The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017
J Todd Kuenstner1, Saleh Naser1, William Chamberlin1
1Temple University Health System, Philadelphia, PA, United States.
Frontiers in Public Health
|October 13, 2017
Summary
Mycobacterium avium ssp. paratuberculosis (MAP) is a zoonotic bacterium concerning both animal and human health. Researchers convened to discuss improving MAP diagnostics and planning future clinical trials for anti-MAP treatments.
Area of Science:
- Microbiology
- Zoonotic Diseases
- Clinical Research
Background:
- Mycobacterium avium ssp. paratuberculosis (MAP) is a zoonotic bacterium.
- There is a shared concern regarding MAP's threat to both animal and human health.
- Current knowledge on MAP's relationship to human disease requires further investigation.
Purpose of the Study:
- To discuss the current knowledge of MAP and its link to human disease.
- To identify strategies for improving diagnostic tests for MAP.
- To plan potential future clinical trials for anti-MAP therapies.
Main Methods:
- A conference was held with international researchers and clinicians.
- Discussions focused on current MAP research and its implications.
- Recommendations were formulated based on a majority consensus.
Main Results:
- Key areas of concern regarding MAP's zoonotic potential were highlighted.
- Methods for enhancing MAP diagnostic accuracy were explored.
- Future research directions, including clinical trials, were considered.
Conclusions:
- Further research and improved diagnostics are crucial for addressing the threat of MAP.
- Collaborative efforts are needed to advance understanding and treatment of MAP-related diseases.
- Conference proceedings offer a summary of current work and expert recommendations.
Related Concept Videos
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis V
660
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
660
Pulmonary Tuberculosis IV
559
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
559
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
732
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
732


